Miromatrix Medical Stock Return On Asset

MIRODelisted Stock  USD 1.49  0.22  12.87%   
Miromatrix Medical fundamentals help investors to digest information that contributes to Miromatrix Medical's financial success or failures. It also enables traders to predict the movement of Miromatrix Stock. The fundamental analysis module provides a way to measure Miromatrix Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Miromatrix Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Miromatrix Medical Company Return On Asset Analysis

Miromatrix Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Miromatrix Medical Return On Asset

    
  -0.56  
Most of Miromatrix Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Miromatrix Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Miromatrix Medical has a Return On Asset of -0.5584. This is 93.62% lower than that of the Biotechnology sector and 97.63% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Miromatrix Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Miromatrix Medical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Miromatrix Medical could also be used in its relative valuation, which is a method of valuing Miromatrix Medical by comparing valuation metrics of similar companies.
Miromatrix Medical is currently under evaluation in return on asset category among its peers.

Miromatrix Fundamentals

About Miromatrix Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Miromatrix Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Miromatrix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Miromatrix Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Miromatrix Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Miromatrix Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Miromatrix Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Miromatrix Stock

  0.7KB KB Financial GroupPairCorr

Moving against Miromatrix Stock

  0.83MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.79TLK Telkom Indonesia TbkPairCorr
  0.77HYMTF Hyundai MotorPairCorr
  0.73EC Ecopetrol SA ADRPairCorr
  0.63PFE Pfizer Inc Aggressive PushPairCorr
The ability to find closely correlated positions to Miromatrix Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Miromatrix Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Miromatrix Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Miromatrix Medical to buy it.
The correlation of Miromatrix Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Miromatrix Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Miromatrix Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Miromatrix Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Miromatrix Stock

If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance